
News Roundup | Study Shows Infected Covid-19 Patients Have Effective and Possibly Long-Term Immunity
Published at : August 25, 2021
Join The Conversation! | https://trialsitenews.com/
Story 1 | Study Led by Fred Hutch & Emory Investigators Shows SARS-CoV-2 Infected Patients Have Broad, Effective & Possibly Long-Term Immunity
A sophisticated team of researchers operating at Fred Hutchinson Cancer Research Center and Emory University suggest that transcending the COVID-19 pandemic necessitates what they refer to as “long-lived immunity to SARS-CoV-2.” Leading a longitudinal study involving 254 COVID-19 patients over an eight-month period, the study team observed what they referred to as “durable broad-based immune responses” in those mild-to-moderate COVID-19 patients.
Article Link | https://trialsitenews.com/study-led-by-fred-hutch-emory-investigators-shows-sars-cov-2-infected-patients-have-broad-effective-possibly-long-term-immunity/
Story 2 | Vaccination Crisis or False Alarm in Israel? 90% of COVID-19 Patients Fully Vaccinated
Israel led the pandemic as an organized, prepared, and aligned population that accepted an aggressive, methodical, and overall successful effort leading to one of the most vaccinated populations against SARS-CoV-2, the virus behind COVID-19. But with the delta variant came breakthrough infections. That is, individuals who were fully vaccinated became infected anyway.
Article Link | https://trialsitenews.com/vaccination-crisis-or-false-alarm-in-israel-90-of-covid-19-patients-fully-vaccinated/
Story 1 | Study Led by Fred Hutch & Emory Investigators Shows SARS-CoV-2 Infected Patients Have Broad, Effective & Possibly Long-Term Immunity
A sophisticated team of researchers operating at Fred Hutchinson Cancer Research Center and Emory University suggest that transcending the COVID-19 pandemic necessitates what they refer to as “long-lived immunity to SARS-CoV-2.” Leading a longitudinal study involving 254 COVID-19 patients over an eight-month period, the study team observed what they referred to as “durable broad-based immune responses” in those mild-to-moderate COVID-19 patients.
Article Link | https://trialsitenews.com/study-led-by-fred-hutch-emory-investigators-shows-sars-cov-2-infected-patients-have-broad-effective-possibly-long-term-immunity/
Story 2 | Vaccination Crisis or False Alarm in Israel? 90% of COVID-19 Patients Fully Vaccinated
Israel led the pandemic as an organized, prepared, and aligned population that accepted an aggressive, methodical, and overall successful effort leading to one of the most vaccinated populations against SARS-CoV-2, the virus behind COVID-19. But with the delta variant came breakthrough infections. That is, individuals who were fully vaccinated became infected anyway.
Article Link | https://trialsitenews.com/vaccination-crisis-or-false-alarm-in-israel-90-of-covid-19-patients-fully-vaccinated/

clinical trialsclinical trials newsclinical research

Breaking ! Tension Rising Between Afghan Group &How Indian Media Crying Over Faiz Hameed Kabul Visit
